Long-term Outcomes of Fixed-Combination Halobetasol Propionate and Tazarotene Lotion Stratified by Baseline Signs and Symptoms of Psoriasis

Main Article Content

Leon Kircik
Lawrence Green
Joshua Zeichner
Javier Alonso-Llamazares
Abby Jacobson

Keywords

psoriasis, halobetasol, tazarotene, long term outcomes

Abstract

N/A

References

1. Lebwohl et al. J Eur Acad Dermatol Venereol. 2021;35:1152-1160.

2. Elmets et al. J Am Acad Dermatol. 2021;84:432-470. 3. Duobrii [package insert]. Bausch Health US, LLC; 2019

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 > >>